
{
  "documentMetadata": {
    "title": "Papillomavirus, Warts",
    "sourceFile": "syndromes/genitourinary/syphilis/Papillomavirus, Warts.pdf",
    "lastUpdated": "2023-01-13"
  },
  "content": [
    {
      "type": "header",
      "level": 2,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Warts: external genital, cervix, vaginal, urethral, anal, skin papillomas.",
        "Associated with cervical and anal cancers (HPV 16, 18)",
        "Associated with head and neck cancers: HPV 16, other serotypes. Reviewed in Head Neck 31:1393, 2009."
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Papillomaviruses",
        "Oncogenic HPV types 16 and 18",
        "  66% of all cervical cancers",
        "  five additional types (6, 11, 31, 33, 45, 52, and 58) targeted by the 9-valent vaccine account for 15%.",
        ">90% genital warts HPV types 6 and 11",
        "Types 6 and 11 also associated with conjunctival, nasal, oral, and laryngeal warts."
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Primary Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "External genital warts:"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Podofilox",
                "dose": "0.5%",
                "route": "solution or gel",
                "frequency": "apply 2x/day x 3 days, 4 days no therapy, repeat cycle 4x"
              }
            ]
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Imiquimod 5% cream",
                "frequency": "apply once daily at bedtime 3x/week on non-consecutive days",
                "dose": "up to 16 weeks"
              },
              {
                "drug": "Imiquimod 3.75% cream",
                "frequency": "apply once daily at bedtime",
                "dose": "up to 8 weeks"
              }
            ],
            "notes": "May weaken condoms and vaginal diaphragms. Treatment area should be washed with soap and water 6â€“10 hours after application"
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Sinecatechins",
                "frequency": "apply to external genital warts only 3x/day until effect or adverse effect (not more than 16 weeks)"
              }
            ]
          }
        },
        {
          "type": "procedure",
          "procedureData": {
            "name": "Cryotherapy with liquid nitrogen",
            "timing": "repeat every 1-2 weeks"
          }
        },
        {
          "type": "procedure",
          "procedureData": {
            "name": "Trichloroacetic acid (TCA) or bichloroacetic acid (BCA) 80%-90% solution",
            "timing": "repeat weekly as needed"
          }
        },
        {
          "type": "procedure",
          "procedureData": {
            "name": "Surgical removal"
          }
        }
      ]
    },
    {
      "type": "list",
      "items": [
        "Persons with external anal or perianal warts might also have intra-anal warts so inspection of the anal canal by digital examination, standard anoscopy, or high-resolution anoscopy should be considered.",
        "No one treatment has been shown to be superior so patient-provider shared decision making recommended."
      ]
    },
    {
      "type": "list",
      "items": [
        "Cervical: Need evaluation for evolving neoplasia. Gynecological exam.",
        "Vaginal: Cryotherapy with liquid nitrogen or TCA",
        "Urethral: Cryotherapy with liquid nitrogen or surgical",
        "Anal: Cryotherapy with liquid nitrogen or TCA or surgical removal. Advise anoscopy to look for rectal warts",
        "Skin papillomas: Topical a-lactalbumin. Oleic acid (from human milk) applied once daily x 3 weeks",
        "Pregnancy and visible genital warts: No need for C-section unless warts are obstructing the birth canal"
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Alternative Regimens"
    },
    {
      "type": "list",
      "items": [
        "None"
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Prevention"
    },
    {
      "type": "crossReference",
      "referenceData": {
        "text": "See Human Papillomavirus, Vaccine for indications, available products, dosing, and vaccine characteristics for pre-exposure prevention.",
        "targetType": "internalDocument",
        "targetIdentifier": "Human Papillomavirus, Vaccine"
      }
    },
    {
      "type": "list",
      "items": [
        "Only 9vHPV vaccine is available in the United States.",
        "now optional consideration in 27-45 yr olds."
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Podofilox: Inexpensive and safe (pregnancy safety not established). Mild irritation after treatment.",
        "Imiquimod: Mild to moderate redness & irritation. Topical imiquimod effective for treatment of vulvar intraepithelial neoplasms (N Engl J Med 358:1465, 2008). Safety in pregnancy not established.",
        "Cryotherapy: blistering and skin necrosis common.",
        "Podophyllin resin: Must air dry before treated area contacts clothing. Can irritate adjacent skin. No longer recommended due to other less toxic treatment availability.",
        "Sinecatechins: Avoid exposure to mucous membranes (vagina, rectum, mouth, eyes). Appears to work best following cryotherapy (J Drugs Dermatol 13:1400, 2014)",
        "TCA: Caustic. Can cause severe pain on adjacent normal skin. Neutralize with soap or sodium bicarbonate.",
        "Topical a-lactalbumin decreased lesion size and recurrence vs placebo (p <0.001) (N Engl J Med 350:2663, 2004). Further studies warranted.",
        "See 2021 CDC STI guidelines MMWR Recomm Rep 70 (RR-4):1 2021 and 2019 IUSTI European guidelines for anogenital warts"
      ]
    }
  ]
}
